| Serial Number | 88035450 |
| Word Mark | IMMUNOSCAPE |
| Filing Date | Thursday, July 12, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 28, 2020 |
| Registration Number | 6039731 |
| Registration Date | Tuesday, April 28, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 11, 2020 |
| Goods and Services | Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 17, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, February 28, 2017 |
| First Use In Commerce Date | Tuesday, February 28, 2017 |
| Party Name | immunoscape Pte Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Singapore 228208 SG |
| Party Name | immunoscape Pte Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Singapore 228208 SG |
| Party Name | immunoscape Pte Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Singapore 228208 SG |
| Event Date | Event Description |
| Tuesday, April 16, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 16, 2018 | NEW APPLICATION ENTERED |
| Tuesday, July 17, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 30, 2018 | ASSIGNED TO EXAMINER |
| Thursday, November 8, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, November 8, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, November 8, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 15, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 15, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 20, 2019 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, April 18, 2019 | LETTER OF SUSPENSION E-MAILED |
| Thursday, April 18, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, April 18, 2019 | SUSPENSION LETTER WRITTEN |
| Friday, April 19, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 12, 2019 | ASSIGNED TO LIE |
| Tuesday, November 19, 2019 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, November 20, 2019 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, November 20, 2019 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, November 22, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, December 3, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 5, 2019 | SUSPENSION LETTER WRITTEN |
| Thursday, December 5, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, December 5, 2019 | LETTER OF SUSPENSION E-MAILED |
| Monday, December 30, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, January 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 8, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 11, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 11, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 28, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 6, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 6, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, September 6, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 3, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, September 3, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, September 3, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 3, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |